Teva Highlights QNAZE(TM) HFA Phase III Data at the 2010 Annual Meeting of the …
MarketWatch (press release) The results, presented at the 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) in Phoenix, Ariz., showed that the … |
View full post on asthma – Google News